Xiao-Fei Sun

Xiao-Fei Sun

Auto-generated profile, based on publicly available information

Xiao-Fei Sun

College of Information Science and Engineering, Zaozhuang University, Zaozhuang 277160, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
lei wanglei wang
lei wang
XYXin Yan
Xin Yan
MLMeng-Lin Liu
Meng-Lin Liu
KSKe-Jian Song
Ke-Jian Song
XSXiao-Fei Sun
Xiao-Fei Sun
WPWen-Wen Pan
Wen-Wen Pan

13 May 2022 in Biology
Verified
Journal Article
Open access
PDF file
lei wanglei wang
lei wang
LWLeon Wong
Leon Wong
ZCZhanheng Chen
Zhanheng Chen
JHJing Hu
Jing Hu
XSXiao-Fei Sun
Xiao-Fei Sun
ZYZhu-Hong You
Zhu-Hong You
The key to new drug discovery and development is first and foremost the search for molecular targets of drugs, thus advancing drug discovery and drug repositioning. However, traditional drug–target interactions (DTIs) is a costly, lengthy, high-risk, and low-success-rate system project. Therefore, more and more pharmaceutical companies are trying to use computational technologies to screen existing drug molecules and mine new drugs, leading to accelerating new drug development. In the current study, we designed a deep learning computational model MSPEDTI based on Molecular Structure and Protein Evolutionary to predict the potential DTIs. The model first fuses protein evolutionary information and drug structure information, then a deep learning convolutional neural network (CNN) to mine its hidden features, and finally accurately predicts the associated DTIs by extreme learning machine (ELM). In cross-validation experiments, MSPEDTI achieved 94.19%, 90.95%, 87.95%, and 86.11% prediction accuracy in the gold-standard datasets enzymes, ion channels, G-protein-coupled receptors (GPCRs), and nuclear receptors, respectively. MSPEDTI showed its competitive ability in ablation experiments and comparison with previous excellent methods. Additionally, 7 of 10 potential DTIs predicted by MSPEDTI were substantiated by the classical database. These excellent outcomes demonstrate the ability of MSPEDTI to provide reliable drug candidate targets and strongly facilitate the development of drug repositioning and drug development.
1